Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

NCT00111618 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: AS1404 (DMXAA)

Sponsor

Antisoma Research